Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 31, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/53/55578    most recent
M408238200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakata, S.
Right arrow Articles by Kanakura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakata, S.
Right arrow Articles by Kanakura, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 13, 2004
J. Biol. Chem, 10.1074/jbc.M408238200
Submitted on July 21, 2004
Revised on September 27, 2004
Accepted on October 13, 2004

NF-KappaB family proteins participates in multiple steps of hematopoiesis through elimination of reactive oxygen species

Soichi Nakata, Itaru Matsumura, Hirokazu Tanaka, Sachiko Ezoe, Yusuke Satoh, Jun Ishikawa, Takumi Era, and Yuzuru Kanakura

Department of Hematology and Oncology, Osaka University, Suita, Osaka 565-0879

Corresponding Author: matumura{at}bldon.med.osaka-u.ac.jp

To examine the roles for NF-kappa B family proteins in hematopoiesis, we first expressed dominant negative Rel/NF-kappa B (Ikappa BSR) in a factor-dependent cell line, Ba/F3. Although Ikappa BSR neither affected TPO-dependent nor gp130-mediated growth, it suppressed IL-3- and EPO-dependent growth at low concentrations. In addition, Ikappa BSR enhanced factor-deprived apoptosis through the accumulation of reactive oxygen species (ROS). When expressed in normal hematopoietic stem/progenitor cells, Ikappa BSR induced apoptosis even in the presence of appropriate cytokines by accumulating ROS. We also expressed Ikappa BSR in an inducible fashion at various stages of hematopoiesis using the OP9 system, in which hematopoietic cells are induced to develop from ES cells. When Ikappa BSR was expressed at the stage of Flk-1+ cells (putative hemangioblasts), Ikappa BSR inhibited the development of primitive hematopoietic progenitor cells by inducing apoptosis through the ROS accumulation. Furthermore, when Ikappa BSR was expressed after the development of hematopoietic progenitor cells, it inhibited their terminal differentiation towards erythrocytes, megakaryocytes, and granulocytes by inducing apoptosis through the ROS accumulation. These results indicate that NF-kappa B is required for preventing apoptosis at multiple steps of hematopoiesis by eliminating ROS.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Satoh, I. Matsumura, H. Tanaka, S. Ezoe, K. Fukushima, M. Tokunaga, M. Yasumi, H. Shibayama, M. Mizuki, T. Era, et al.
AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells
J. Biol. Chem., October 31, 2008; 283(44): 30045 - 30056.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. D. Erusalimsky and S. Moncada
Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2524 - 2531.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. Naujokat and T. Saric
Concise Review: Role and Function of the Ubiquitin-Proteasome System in Mammalian Stem and Progenitor Cells
Stem Cells, October 1, 2007; 25(10): 2408 - 2418.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
D. Cilloni, G. Martinelli, F. Messa, M. Baccarani, and G. Saglio
Nuclear factor {kappa}B as a target for new drug development in myeloid malignancies
Haematologica, September 1, 2007; 92(9): 1224 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago
Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors
Stem Cells, January 1, 2007; 25(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Um and H. F. Lodish
Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways
J. Biol. Chem., March 3, 2006; 281(9): 5648 - 5656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement